Technology | 2021.05.04
Palatin Announces U.S. Patent Term Extension for Vyleesi® (bremelanotide injection)
CRANBURY, N.J., May 4, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor systems, today announced that the United States...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]otide-injection-301282905.html
Follow us on
📊 Most Viewed News
- • The complete guide to making your product international - The Nex... (15,542)
- • Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,035)
- • A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,530)
- • Immigrants 'should learn English' - Politics.co.uk (11,211)
- • How OpenStack gets translated - opensource.com (11,048)
- • easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,937)
- • Para-Plus Translations Honored by Philadelphia Business Journal .... (10,367)
- • Google Adds Customized Translations for Website Owners - PC Magaz... (10,257)